HF
JANX icon

HRT Financial’s Janux Therapeutics JANX Stock Holding History

HRT Financial’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Sell
17,300
-32,900
-66% -$477K ﹤0.01% 3180
2026
Q1 		$697K Buy
+50,200
New +$688K ﹤0.01% 2292

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

HRT Financial's JANX Position: Q2 2026 in Review

HRT Financial increased its Janux Therapeutics (JANX) stake by 34% in Q2 2026, buying an estimated $1.8M and bringing the position to 491,001 shares worth $7.54M. The position accounts for 0.01% of the portfolio, ranked #917.

HRT Financial first reported a position in JANX in Q4 2022 and has held it in 4 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • HRT Financial held 491,001 shares of Janux Therapeutics worth $7.54M as of Q2 2026.
  • HRT Financial bought 124,302 Janux Therapeutics shares in Q2 2026, an estimated $1.8M.
  • Janux Therapeutics made up 0.01% of HRT Financial's portfolio in Q2 2026, its #917 holding.
  • HRT Financial first reported a position in Janux Therapeutics in Q4 2022 and has held it in 4 quarters since.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.